Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
ADM_13083841
Potential treatment - theoretical effect Experimental Antiviral Aug/28/2020
YKYRYL peptide
Potential treatment - theoretical effect Experimental Antiviral Aug/27/2020
GC373
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/27/2020
(E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
Potential treatment - theoretical effect Experimental Antiviral Aug/26/2020
CM06
Potential treatment - theoretical effect Experimental Antiviral Aug/26/2020
CM02
Potential treatment - theoretical effect Experimental Antiviral Aug/26/2020
AOaV-1-SARS-CoV-2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/24/2020
Tegobuvir
Potential treatment - theoretical effect Experimental Antiviral Aug/24/2020
A_BR18
Potential treatment - theoretical effect Experimental Antiviral Aug/23/2020
A_BR28
Potential treatment - theoretical effect Experimental Antiviral Aug/23/2020
MAb362
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/21/2020
Ad5-S-nb2
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/21/2020
Birinapant
Potential treatment - theoretical effect Experimental Antiviral Aug/20/2020
Dynasore
Potential treatment - theoretical effect Experimental Antiviral Aug/20/2020
Autologous conditioned serum
Potential treatment - clinical evidence Experimental Other treatment Aug/20/2020
RQ3013-VLP
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020
89C8-ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/17/2020
Ad5-nCoV
Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020
WIV04 strain vaccine
Potential treatment - clinical evidence Experimental Vaccine Aug/13/2020
BNT162b1
Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020